𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new classification of generalized carcinoma of the breast based on response to therapy

✍ Scribed by Dr. Dennis V. Razis

Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
304 KB
Volume
8
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Classifications of generalized carcinoma of the breast were based up to now on factors of definitely proven prognostic significance. These classifications are very useful in defining prognosis, but they help only to a limited extent in selecting treatment. We are proposing a new classification of three groups for generalized carcinoma of the breast according to objective response to therapy: to (a) responders, (b) nonresponders, and (c) patients with static disease. It is pointed out that in some cases there is discrepancy between prognosis and response to therapy, as some patients with β€œpoor prognosis” respond dramatically to treatment while others with β€œgood prognosis” do not respond to any type of treatment and treatment is actually harmful. It is also pointed out that our classificaiton has a dynamic meaning, as a patient can switch from one group to another. The proposed classification might be of more help in deciding the therapeutic management.

πŸ“œ SIMILAR VOLUMES

Nevus of Ota: A new classification based
Nevus of Ota: A new classification based on the response to laser treatment
✍ Henry H. Chan; Lai-kun Lam; David S.Y. Wong; Ronald S.C. Leung; Shun-yuen Ying; πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 225 KB

## Abstract ## Background and Objective For 60 years, Tanino's classification has been used to classify the extent of nevus of Ota. However, such classification not only fails to address variants such as phacomatosis pigmentovascularis but also cannot be used to predict the therapeutic outcome. Ou

Use of oesophagogastroscopy to assess th
Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy
✍ W. A. Brown; J. Thomas; D. Gotley; B. H. Burmeister; K.-H. Lim; I. Martin; E. T. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

## Abstract ## Background Approximately 25 per cent of patients with oesophageal cancer who undergo neoadjuvant chemoradiotherapy have no evidence of tumour in the resected specimen (complete pathological response). Those who do not respond have a poor 5-year survival compared with complete respon

The response to further chemotherapy in
The response to further chemotherapy in patients with carcinoma of the breast who progressed while receiving adjuvant therapy
✍ Don M. Morris; E. George Elias; Mukund S. Didolkar; Sally D. Brown πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 350 KB

The effect of known chemotherapeutic programs in patients with breast cancer who developed metastasis during or after adjuvant chemotherapy with L-PAM plus 5-FU (PF) were studied. Thirteen patients failed while receiving adjuvant therapy at 3-22 months from the time therapy started. Three patients f